PolyPid Ltd
(NASDAQ:PYPD)
$0.79
-0.0296[-3.61%]
At close: Feb 3
$0.7781
-0.0119[-1.51%]
After Hours: 7:23PM EDT
Day Range0.780 - 0.84052 Wk Range0.650 - 6.900Open / Close0.820 / 0.790Float / Outstanding16.676M / 19.656M
Vol / Avg.92.549K / 364.259KMkt Cap15.528MP/E-50d Avg. Price0.790
Div / Yield (Forward)- / -%Payout Ratio-Total Float16.676MEPS-2.430

PolyPid Stock (NASDAQ:PYPD), Quotes and News Summary

PolyPid Stock (NASDAQ: PYPD) stock price, news, charts, stock research, profile.

Loading...
Day Range0.780 - 0.84052 Wk Range0.650 - 6.900Open / Close0.820 / 0.790Float / Outstanding16.676M / 19.656M
Vol / Avg.92.549K / 364.259KMkt Cap15.528MP/E-50d Avg. Price0.790
Div / Yield (Forward)- / -%Payout Ratio-Total Float16.676MEPS-2.430
Globe Newswire - Oct 20, 2022, 7:09AM
Globe Newswire - Mar 8, 2022, 7:00AM
Seeking Alpha - Nov 12, 2022, 3:29PM
TipRanks - Nov 9, 2022, 2:45PM
InvestorsObserver - Sep 21, 2022, 10:46AM
InvestorsObserver - Sep 15, 2022, 11:35AM
InvestorsObserver - Sep 13, 2022, 6:46AM
InvestorsObserver - Sep 12, 2022, 2:27PM
InvestorsObserver - Sep 6, 2022, 8:36AM
Seeking Alpha - Sep 2, 2022, 1:26PM
TipRanks - Sep 2, 2022, 12:15PM
TipRanks - Aug 3, 2022, 12:25PM
InvestorsObserver - Jul 26, 2022, 1:05PM
PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, BonyPid-1000, BonyPid-500, PLEX, and D-PLEX are trademarks of the Company. The Company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-08
REV
Q3 2022Est.ActualSurprise
EPS-0.540-0.480 0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy PolyPid (PYPD) stock?

A

You can purchase shares of PolyPid (NASDAQ: PYPD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are PolyPid's (PYPD) competitors?

A

There are no as such competitors for PolyPid.

Q

What is the target price for PolyPid (PYPD) stock?

A

The latest price target for PolyPid (NASDAQ: PYPD) was reported by Barclays on Wednesday, September 7, 2022. The analyst firm set a price target for 2.50 expecting PYPD to rise to within 12 months (a possible 216.46% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for PolyPid (PYPD)?

A

The stock price for PolyPid (NASDAQ: PYPD) is $0.79 last updated February 3, 2023 at 8:59 PM UTC.

Q

Does PolyPid (PYPD) pay a dividend?

A

There are no upcoming dividends for PolyPid.

Q

When is PolyPid (NASDAQ:PYPD) reporting earnings?

A

PolyPid’s Q4 earnings are confirmed for Wednesday, February 8, 2023.

Q

Is PolyPid (PYPD) going to split?

A

There is no upcoming split for PolyPid.

Q

What sector and industry does PolyPid (PYPD) operate in?

A

PolyPid is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

PolyPid Stock (NASDAQ:PYPD), Quotes and News Summary

PolyPid Stock (NASDAQ: PYPD) stock price, news, charts, stock research, profile.

Loading...
Day Range0.780 - 0.84052 Wk Range0.650 - 6.900Open / Close0.820 / 0.790Float / Outstanding16.676M / 19.656M
Vol / Avg.92.549K / 364.259KMkt Cap15.528MP/E-50d Avg. Price0.790
Div / Yield (Forward)- / -%Payout Ratio-Total Float16.676MEPS-2.430
Globe Newswire - Oct 20, 2022, 7:09AM
Globe Newswire - Mar 8, 2022, 7:00AM
Seeking Alpha - Nov 12, 2022, 3:29PM
TipRanks - Nov 9, 2022, 2:45PM
InvestorsObserver - Sep 21, 2022, 10:46AM
InvestorsObserver - Sep 15, 2022, 11:35AM
InvestorsObserver - Sep 13, 2022, 6:46AM
InvestorsObserver - Sep 12, 2022, 2:27PM
InvestorsObserver - Sep 6, 2022, 8:36AM
Seeking Alpha - Sep 2, 2022, 1:26PM
TipRanks - Sep 2, 2022, 12:15PM
TipRanks - Aug 3, 2022, 12:25PM
InvestorsObserver - Jul 26, 2022, 1:05PM
PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, BonyPid-1000, BonyPid-500, PLEX, and D-PLEX are trademarks of the Company. The Company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-08
REV
Q3 2022Est.ActualSurprise
EPS-0.540-0.480 0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy PolyPid (PYPD) stock?

A

You can purchase shares of PolyPid (NASDAQ: PYPD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are PolyPid's (PYPD) competitors?

A

There are no as such competitors for PolyPid.

Q

What is the target price for PolyPid (PYPD) stock?

A

The latest price target for PolyPid (NASDAQ: PYPD) was reported by Barclays on Wednesday, September 7, 2022. The analyst firm set a price target for 2.50 expecting PYPD to rise to within 12 months (a possible 216.46% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for PolyPid (PYPD)?

A

The stock price for PolyPid (NASDAQ: PYPD) is $0.79 last updated February 3, 2023 at 8:59 PM UTC.

Q

Does PolyPid (PYPD) pay a dividend?

A

There are no upcoming dividends for PolyPid.

Q

When is PolyPid (NASDAQ:PYPD) reporting earnings?

A

PolyPid’s Q4 earnings are confirmed for Wednesday, February 8, 2023.

Q

Is PolyPid (PYPD) going to split?

A

There is no upcoming split for PolyPid.

Q

What sector and industry does PolyPid (PYPD) operate in?

A

PolyPid is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

PolyPid Stock (NASDAQ:PYPD), Quotes and News Summary

PolyPid Stock (NASDAQ: PYPD) stock price, news, charts, stock research, profile.

Loading...
Day Range0.780 - 0.84052 Wk Range0.650 - 6.900Open / Close0.820 / 0.790Float / Outstanding16.676M / 19.656M
Vol / Avg.92.549K / 364.259KMkt Cap15.528MP/E-50d Avg. Price0.790
Div / Yield (Forward)- / -%Payout Ratio-Total Float16.676MEPS-2.430
Globe Newswire - Oct 20, 2022, 7:09AM
Globe Newswire - Mar 8, 2022, 7:00AM
Seeking Alpha - Nov 12, 2022, 3:29PM
TipRanks - Nov 9, 2022, 2:45PM
InvestorsObserver - Sep 21, 2022, 10:46AM
InvestorsObserver - Sep 15, 2022, 11:35AM
InvestorsObserver - Sep 13, 2022, 6:46AM
InvestorsObserver - Sep 12, 2022, 2:27PM
InvestorsObserver - Sep 6, 2022, 8:36AM
Seeking Alpha - Sep 2, 2022, 1:26PM
TipRanks - Sep 2, 2022, 12:15PM
TipRanks - Aug 3, 2022, 12:25PM
InvestorsObserver - Jul 26, 2022, 1:05PM
PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, BonyPid-1000, BonyPid-500, PLEX, and D-PLEX are trademarks of the Company. The Company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-08
REV
Q3 2022Est.ActualSurprise
EPS-0.540-0.480 0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy PolyPid (PYPD) stock?

A

You can purchase shares of PolyPid (NASDAQ: PYPD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are PolyPid's (PYPD) competitors?

A

There are no as such competitors for PolyPid.

Q

What is the target price for PolyPid (PYPD) stock?

A

The latest price target for PolyPid (NASDAQ: PYPD) was reported by Barclays on Wednesday, September 7, 2022. The analyst firm set a price target for 2.50 expecting PYPD to rise to within 12 months (a possible 216.46% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for PolyPid (PYPD)?

A

The stock price for PolyPid (NASDAQ: PYPD) is $0.79 last updated February 3, 2023 at 8:59 PM UTC.

Q

Does PolyPid (PYPD) pay a dividend?

A

There are no upcoming dividends for PolyPid.

Q

When is PolyPid (NASDAQ:PYPD) reporting earnings?

A

PolyPid’s Q4 earnings are confirmed for Wednesday, February 8, 2023.

Q

Is PolyPid (PYPD) going to split?

A

There is no upcoming split for PolyPid.

Q

What sector and industry does PolyPid (PYPD) operate in?

A

PolyPid is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

PolyPid Stock (NASDAQ:PYPD), Quotes and News Summary

PolyPid Stock (NASDAQ: PYPD) stock price, news, charts, stock research, profile.

Loading...
Day Range0.780 - 0.84052 Wk Range0.650 - 6.900Open / Close0.820 / 0.790Float / Outstanding16.676M / 19.656M
Vol / Avg.92.549K / 364.259KMkt Cap15.528MP/E-50d Avg. Price0.790
Div / Yield (Forward)- / -%Payout Ratio-Total Float16.676MEPS-2.430
Globe Newswire - Oct 20, 2022, 7:09AM
Globe Newswire - Mar 8, 2022, 7:00AM
Seeking Alpha - Nov 12, 2022, 3:29PM
TipRanks - Nov 9, 2022, 2:45PM
InvestorsObserver - Sep 21, 2022, 10:46AM
InvestorsObserver - Sep 15, 2022, 11:35AM
InvestorsObserver - Sep 13, 2022, 6:46AM
InvestorsObserver - Sep 12, 2022, 2:27PM
InvestorsObserver - Sep 6, 2022, 8:36AM
Seeking Alpha - Sep 2, 2022, 1:26PM
TipRanks - Sep 2, 2022, 12:15PM
TipRanks - Aug 3, 2022, 12:25PM
InvestorsObserver - Jul 26, 2022, 1:05PM
PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, BonyPid-1000, BonyPid-500, PLEX, and D-PLEX are trademarks of the Company. The Company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-08
REV
Q3 2022Est.ActualSurprise
EPS-0.540-0.480 0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy PolyPid (PYPD) stock?

A

You can purchase shares of PolyPid (NASDAQ: PYPD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are PolyPid's (PYPD) competitors?

A

There are no as such competitors for PolyPid.

Q

What is the target price for PolyPid (PYPD) stock?

A

The latest price target for PolyPid (NASDAQ: PYPD) was reported by Barclays on Wednesday, September 7, 2022. The analyst firm set a price target for 2.50 expecting PYPD to rise to within 12 months (a possible 216.46% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for PolyPid (PYPD)?

A

The stock price for PolyPid (NASDAQ: PYPD) is $0.79 last updated February 3, 2023 at 8:59 PM UTC.

Q

Does PolyPid (PYPD) pay a dividend?

A

There are no upcoming dividends for PolyPid.

Q

When is PolyPid (NASDAQ:PYPD) reporting earnings?

A

PolyPid’s Q4 earnings are confirmed for Wednesday, February 8, 2023.

Q

Is PolyPid (PYPD) going to split?

A

There is no upcoming split for PolyPid.

Q

What sector and industry does PolyPid (PYPD) operate in?

A

PolyPid is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

PolyPid Stock (NASDAQ:PYPD), Quotes and News Summary

PolyPid Stock (NASDAQ: PYPD) stock price, news, charts, stock research, profile.

Loading...
Day Range0.780 - 0.84052 Wk Range0.650 - 6.900Open / Close0.820 / 0.790Float / Outstanding16.676M / 19.656M
Vol / Avg.92.549K / 364.259KMkt Cap15.528MP/E-50d Avg. Price0.790
Div / Yield (Forward)- / -%Payout Ratio-Total Float16.676MEPS-2.430
Globe Newswire - Oct 20, 2022, 7:09AM
Globe Newswire - Mar 8, 2022, 7:00AM
Seeking Alpha - Nov 12, 2022, 3:29PM
TipRanks - Nov 9, 2022, 2:45PM
InvestorsObserver - Sep 21, 2022, 10:46AM
InvestorsObserver - Sep 15, 2022, 11:35AM
InvestorsObserver - Sep 13, 2022, 6:46AM
InvestorsObserver - Sep 12, 2022, 2:27PM
InvestorsObserver - Sep 6, 2022, 8:36AM
Seeking Alpha - Sep 2, 2022, 1:26PM
TipRanks - Sep 2, 2022, 12:15PM
TipRanks - Aug 3, 2022, 12:25PM
InvestorsObserver - Jul 26, 2022, 1:05PM
PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, BonyPid-1000, BonyPid-500, PLEX, and D-PLEX are trademarks of the Company. The Company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-08
REV
Q3 2022Est.ActualSurprise
EPS-0.540-0.480 0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy PolyPid (PYPD) stock?

A

You can purchase shares of PolyPid (NASDAQ: PYPD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are PolyPid's (PYPD) competitors?

A

There are no as such competitors for PolyPid.

Q

What is the target price for PolyPid (PYPD) stock?

A

The latest price target for PolyPid (NASDAQ: PYPD) was reported by Barclays on Wednesday, September 7, 2022. The analyst firm set a price target for 2.50 expecting PYPD to rise to within 12 months (a possible 216.46% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for PolyPid (PYPD)?

A

The stock price for PolyPid (NASDAQ: PYPD) is $0.79 last updated February 3, 2023 at 8:59 PM UTC.

Q

Does PolyPid (PYPD) pay a dividend?

A

There are no upcoming dividends for PolyPid.

Q

When is PolyPid (NASDAQ:PYPD) reporting earnings?

A

PolyPid’s Q4 earnings are confirmed for Wednesday, February 8, 2023.

Q

Is PolyPid (PYPD) going to split?

A

There is no upcoming split for PolyPid.

Q

What sector and industry does PolyPid (PYPD) operate in?

A

PolyPid is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

PolyPid Stock (NASDAQ:PYPD), Quotes and News Summary

PolyPid Stock (NASDAQ: PYPD) stock price, news, charts, stock research, profile.

Loading...
Day Range0.780 - 0.84052 Wk Range0.650 - 6.900Open / Close0.820 / 0.790Float / Outstanding16.676M / 19.656M
Vol / Avg.92.549K / 364.259KMkt Cap15.528MP/E-50d Avg. Price0.790
Div / Yield (Forward)- / -%Payout Ratio-Total Float16.676MEPS-2.430
Globe Newswire - Oct 20, 2022, 7:09AM
Globe Newswire - Mar 8, 2022, 7:00AM
Seeking Alpha - Nov 12, 2022, 3:29PM
TipRanks - Nov 9, 2022, 2:45PM
InvestorsObserver - Sep 21, 2022, 10:46AM
InvestorsObserver - Sep 15, 2022, 11:35AM
InvestorsObserver - Sep 13, 2022, 6:46AM
InvestorsObserver - Sep 12, 2022, 2:27PM
InvestorsObserver - Sep 6, 2022, 8:36AM
Seeking Alpha - Sep 2, 2022, 1:26PM
TipRanks - Sep 2, 2022, 12:15PM
TipRanks - Aug 3, 2022, 12:25PM
InvestorsObserver - Jul 26, 2022, 1:05PM
PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, BonyPid-1000, BonyPid-500, PLEX, and D-PLEX are trademarks of the Company. The Company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-08
REV
Q3 2022Est.ActualSurprise
EPS-0.540-0.480 0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy PolyPid (PYPD) stock?

A

You can purchase shares of PolyPid (NASDAQ: PYPD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are PolyPid's (PYPD) competitors?

A

There are no as such competitors for PolyPid.

Q

What is the target price for PolyPid (PYPD) stock?

A

The latest price target for PolyPid (NASDAQ: PYPD) was reported by Barclays on Wednesday, September 7, 2022. The analyst firm set a price target for 2.50 expecting PYPD to rise to within 12 months (a possible 216.46% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for PolyPid (PYPD)?

A

The stock price for PolyPid (NASDAQ: PYPD) is $0.79 last updated February 3, 2023 at 8:59 PM UTC.

Q

Does PolyPid (PYPD) pay a dividend?

A

There are no upcoming dividends for PolyPid.

Q

When is PolyPid (NASDAQ:PYPD) reporting earnings?

A

PolyPid’s Q4 earnings are confirmed for Wednesday, February 8, 2023.

Q

Is PolyPid (PYPD) going to split?

A

There is no upcoming split for PolyPid.

Q

What sector and industry does PolyPid (PYPD) operate in?

A

PolyPid is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

PolyPid Stock (NASDAQ:PYPD), Quotes and News Summary

PolyPid Stock (NASDAQ: PYPD) stock price, news, charts, stock research, profile.

Loading...
Day Range0.780 - 0.84052 Wk Range0.650 - 6.900Open / Close0.820 / 0.790Float / Outstanding16.676M / 19.656M
Vol / Avg.92.549K / 364.259KMkt Cap15.528MP/E-50d Avg. Price0.790
Div / Yield (Forward)- / -%Payout Ratio-Total Float16.676MEPS-2.430
Globe Newswire - Oct 20, 2022, 7:09AM
Globe Newswire - Mar 8, 2022, 7:00AM
Seeking Alpha - Nov 12, 2022, 3:29PM
TipRanks - Nov 9, 2022, 2:45PM
InvestorsObserver - Sep 21, 2022, 10:46AM
InvestorsObserver - Sep 15, 2022, 11:35AM
InvestorsObserver - Sep 13, 2022, 6:46AM
InvestorsObserver - Sep 12, 2022, 2:27PM
InvestorsObserver - Sep 6, 2022, 8:36AM
Seeking Alpha - Sep 2, 2022, 1:26PM
TipRanks - Sep 2, 2022, 12:15PM
TipRanks - Aug 3, 2022, 12:25PM
InvestorsObserver - Jul 26, 2022, 1:05PM
PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, BonyPid-1000, BonyPid-500, PLEX, and D-PLEX are trademarks of the Company. The Company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-08
REV
Q3 2022Est.ActualSurprise
EPS-0.540-0.480 0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy PolyPid (PYPD) stock?

A

You can purchase shares of PolyPid (NASDAQ: PYPD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are PolyPid's (PYPD) competitors?

A

There are no as such competitors for PolyPid.

Q

What is the target price for PolyPid (PYPD) stock?

A

The latest price target for PolyPid (NASDAQ: PYPD) was reported by Barclays on Wednesday, September 7, 2022. The analyst firm set a price target for 2.50 expecting PYPD to rise to within 12 months (a possible 216.46% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for PolyPid (PYPD)?

A

The stock price for PolyPid (NASDAQ: PYPD) is $0.79 last updated February 3, 2023 at 8:59 PM UTC.

Q

Does PolyPid (PYPD) pay a dividend?

A

There are no upcoming dividends for PolyPid.

Q

When is PolyPid (NASDAQ:PYPD) reporting earnings?

A

PolyPid’s Q4 earnings are confirmed for Wednesday, February 8, 2023.

Q

Is PolyPid (PYPD) going to split?

A

There is no upcoming split for PolyPid.

Q

What sector and industry does PolyPid (PYPD) operate in?

A

PolyPid is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

PolyPid Stock (NASDAQ:PYPD), Quotes and News Summary

PolyPid Stock (NASDAQ: PYPD) stock price, news, charts, stock research, profile.

Loading...
Day Range0.780 - 0.84052 Wk Range0.650 - 6.900Open / Close0.820 / 0.790Float / Outstanding16.676M / 19.656M
Vol / Avg.92.549K / 364.259KMkt Cap15.528MP/E-50d Avg. Price0.790
Div / Yield (Forward)- / -%Payout Ratio-Total Float16.676MEPS-2.430
Globe Newswire - Oct 20, 2022, 7:09AM
Globe Newswire - Mar 8, 2022, 7:00AM
Seeking Alpha - Nov 12, 2022, 3:29PM
TipRanks - Nov 9, 2022, 2:45PM
InvestorsObserver - Sep 21, 2022, 10:46AM
InvestorsObserver - Sep 15, 2022, 11:35AM
InvestorsObserver - Sep 13, 2022, 6:46AM
InvestorsObserver - Sep 12, 2022, 2:27PM
InvestorsObserver - Sep 6, 2022, 8:36AM
Seeking Alpha - Sep 2, 2022, 1:26PM
TipRanks - Sep 2, 2022, 12:15PM
TipRanks - Aug 3, 2022, 12:25PM
InvestorsObserver - Jul 26, 2022, 1:05PM
PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, BonyPid-1000, BonyPid-500, PLEX, and D-PLEX are trademarks of the Company. The Company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-08
REV
Q3 2022Est.ActualSurprise
EPS-0.540-0.480 0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy PolyPid (PYPD) stock?

A

You can purchase shares of PolyPid (NASDAQ: PYPD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are PolyPid's (PYPD) competitors?

A

There are no as such competitors for PolyPid.

Q

What is the target price for PolyPid (PYPD) stock?

A

The latest price target for PolyPid (NASDAQ: PYPD) was reported by Barclays on Wednesday, September 7, 2022. The analyst firm set a price target for 2.50 expecting PYPD to rise to within 12 months (a possible 216.46% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for PolyPid (PYPD)?

A

The stock price for PolyPid (NASDAQ: PYPD) is $0.79 last updated February 3, 2023 at 8:59 PM UTC.

Q

Does PolyPid (PYPD) pay a dividend?

A

There are no upcoming dividends for PolyPid.

Q

When is PolyPid (NASDAQ:PYPD) reporting earnings?

A

PolyPid’s Q4 earnings are confirmed for Wednesday, February 8, 2023.

Q

Is PolyPid (PYPD) going to split?

A

There is no upcoming split for PolyPid.

Q

What sector and industry does PolyPid (PYPD) operate in?

A

PolyPid is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.